EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MaxCyte's enterprise value is $361.25 Mil.
MaxCyte's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $44.06 Mil. Therefore, MaxCyte's EV-to-Revenue for today is 8.20.
The historical rank and industry rank for MaxCyte's EV-to-Revenue or its related term are showing as below:
MXCT'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.48 Med: 9.91 Max: 52.02
Current: 8.2
During the past 12 years, the highest EV-to-Revenue of MaxCyte was 52.02. The lowest was 2.48. And the median was 9.91.
MXCT's EV-to-Revenue is ranked worse than 78.77% of 829
companies
in the Medical Devices & Instruments industry
Industry Median: 3.17
vs MXCT: 8.20
As of today (2024-05-30), MaxCyte's stock price is $4.65.
MaxCyte's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.43. Therefore, MaxCyte's PS Ratio for today is 10.94.
MaxCyte EV-to-Revenue Historical Data
The historical data trend for MaxCyte's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, MaxCyte's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MaxCyte's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MaxCyte's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where MaxCyte's EV-to-Revenue falls into.
MaxCyte's current Enterprise Value is $361.25 Mil.
MaxCyte's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MaxCyte's share price for today is $4.65.
MaxCyte's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MaxCyte EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of MaxCyte's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MXCT has been successfully added to your 